# Design Therapeutics (DSGN) — Analyst Forecast

DSGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/dsgn/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 2, 2026 | Wells Fargo | Initiated Coverage | Overweight | $26.00 |
| May 4, 2026 | Oppenheimer | Maintained | Outperform | $21.00 |
| Mar 16, 2026 | Jefferies | Initiated Coverage | Buy | $15.00 |
| Mar 10, 2026 | RBC Capital | Maintained | Outperform | $14.00 |
| Jan 7, 2026 | Oppenheimer | Initiated Coverage | Outperform | $18.00 |
| Dec 3, 2025 | Leerink Partners | Upgraded | Market Perform → Outperform | $14.00 |
| Nov 20, 2025 | RBC Capital | Upgraded | Sector Perform → Outperform | $13.00 |
| Nov 6, 2025 | RBC Capital | Maintained | Sector Perform | $6.00 |
| Aug 6, 2024 | RBC Capital | Maintained | Sector Perform | $4.00 |
| May 7, 2024 | Piper Sandler | Upgraded | Neutral → Overweight | $12.00 |
| Mar 20, 2024 | Wedbush | Maintained | Neutral | $5.00 |
| Mar 20, 2024 | RBC Capital | Maintained | Sector Perform | $4.00 |
| Nov 14, 2023 | RBC Capital | Maintained | Sector Perform | $4.00 |
| Aug 15, 2023 | Wedbush | Downgraded | Outperform → Neutral | $6.00 |
| Aug 15, 2023 | SVB Leerink | Downgraded | Outperform → Market Perform | $6.00 |
| Aug 15, 2023 | RBC Capital | Downgraded | Outperform → Sector Perform | $7.00 |
| May 10, 2023 | Wedbush | Maintained | Outperform | $19.00 |
| May 10, 2023 | RBC Capital | Maintained | Outperform | $23.00 |
| May 4, 2023 | Goldman Sachs | Upgraded | Sell → Neutral | — |

## Frequently Asked Questions

### What is the latest analyst rating on DSGN?

On Oct 2, 2026, Wells Fargo initiated coverage of Design Therapeutics at Overweight with a price target of $26.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).